Toll-like Receptor agonists and alpha-galactosylceramide synergistically enhance the production of interferon-gamma in murine splenocytes

Vα14 natural killer T (iNKT) cells activated by alpha-galactosylceramide (GalCer) secrete a large amount of cytokines. Toll-like receptors (TLRs) play a critical role in the innate immune responses via the recognition of pathological antigen. Previously we demonstrated that the iNKT cells activated by GalCer augmented LPS-induced NO production in peritoneal cells. In this study, we examined the effect of GalCer and TLR agonists by IFN-γ production from splenocytes. Splenocytes pretreated with GalCer induced TLR3, 4, 7/8 and 9 agonists in vitro, resulting in the enhancement of IFN-γ mRNA expression. In particular, IFN-γ stimulated by GalCer and LPS was increased in NK cells and CD8 T cells and inhibited by a neutralizing anti-IL-12 antibody. Pretreatment with GalCer enhanced the phosphorylation of IκB-α induced by LPS stimulation. The present study showed that co-stimulation of GalCer and TLR agonists powerfully induced the production of IFN-γ from splenocytes.

• Publication year

  2013

• Venue

  Scientific Reports

• Publication date

  2013-09-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/srep02559PMID 23994875PMCID 3759050
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphoma.

  2012cited by this paper
• IL-10–induced microRNA-187 negatively regulates TNF-α, IL-6, and IL-12p40 production in TLR4-stimulated monocytes

  2012cited by this paper
• Activated iNKT Cells Promote Memory CD8+ T Cell Differentiation during Viral Infection

  2012cited by this paper
• High susceptibility to lipopolysaccharide-induced lethal shock in encephalomyocarditis virus-infected mice

  2012cited by this paper
• Natural Killer (NK) Cells in Antibacterial Innate Immunity: Angels or Devils?

  2012cited by this paper
• The Two Faces of Interferon-γ in Cancer

  2011cited by this paper
• TLR-based immune adjuvants.

  2011cited by this paper
• A New Subset of CD103+CD8α+ Dendritic Cells in the Small Intestine Expresses TLR3, TLR7, and TLR9 and Induces Th1 Response and CTL Activity

  2011cited by this paper
• Memory, Visual Discrimination Performance, and the Human Hippocampus

  2011cited by this paper
• Exhausted CD8 T Cells Downregulate the IL-18 Receptor and Become Unresponsive to Inflammatory Cytokines and Bacterial Co-infections

  2011cited by this paper
• High doses of α-galactosylceramide potentiate experimental autoimmune encephalomyelitis by directly enhancing Th17 response

  2010cited by this paper
• Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

  2010cited by this paper
• Adjuvant activity mediated by iNKT cells.

  2010cited by this paper
• Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.

  2009cited by this paper
• Toll-like receptors and their role in hematologic malignancies.

  2009cited by this paper
• Novel multi‐peptide vaccination in Hla‐A2+ hormone sensitive patients with biochemical relapse of prostate cancer

  2009cited by this paper
• Synthetic Double-Stranded RNAs Are Adjuvants for the Induction of T Helper 1 and Humoral Immune Responses to Human Papillomavirus in Rhesus Macaques

  2009cited by this paper
• α-Galactosylceramide in Chronic Hepatitis B Infection: Results from a Randomized Placebo-Controlled Phase I/ II Trial

  2009cited by this paper
• Valpha14 NKT cells activated by alpha-galactosylceramide augment lipopolysaccharide-induced nitric oxide production in mouse intra-hepatic lymphocytes.

  2009cited by this paper
• Role of Valpha14+ NKT cells in the development of Hepatitis B virus-specific CTL: activation of Valpha14+ NKT cells promotes the breakage of CTL tolerance.

  2008cited by this paper
• Immunization of Malignant Melanoma Patients with Full-Length NY-ESO-1 Protein Using TLR7 Agonist Imiquimod as Vaccine Adjuvant1

  2008cited by this paper
• Randomized placebo controlled phase I/II trial of alpha-galactosylceramide for the treatment of chronic hepatitis C.

  2007cited by this paper
• Randomized placebo controlled phase I/II trial of α-galactosylceramide for the treatment of chronic hepatitis C

  2007cited by this paper
• Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults.

  2006cited by this paper
• Lethal endotoxic shock using alpha-galactosylceramide sensitization as a new experimental model of septic shock.

  2006cited by this paper
• Toward an understanding of NKT cell biology: progress and paradoxes.

  2005cited by this paper
• Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909.

  2005cited by this paper
• Immunization with HIV-1 Gag Protein Conjugated to a TLR7/8 Agonist Results in the Generation of HIV-1 Gag-Specific Th1 and CD8+ T Cell Responses

  2005cited by this paper
• Augmentation of lipopolysaccharide-induced nitric oxide production by α-galactosylceramide in mouse peritoneal cells

  2005cited by this paper
• Interferon-gamma: an overview of signals, mechanisms and functions.

  2004cited by this paper
• Immunologic Analysis of a Phase I/II Study of Vaccination with MAGE-3 Protein Combined with the AS02B Adjuvant in Patients with MAGE-3-Positive Tumors

  2004cited by this paper
• Safety and immunogenicity profile of an experimental hepatitis B vaccine adjuvanted with AS04.

  2004cited by this paper
• Interferon- : an overview of signals, mechanisms and functions

  2004cited by this paper
• The Regulatory Role of Vα14 NKT Cells in Innate and Acquired Immune Response

  2003cited by this paper
• Superior Protection against Malaria and Melanoma Metastases by a C-glycoside Analogue of the Natural Killer T Cell Ligand α-Galactosylceramide

  2003cited by this paper
• The regulatory role of Valpha14 NKT cells in innate and acquired immune response.

  2003cited by this paper
• Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: overall results of a randomized trial of the Southwest Oncology Group.

  2002cited by this paper

• Rapid protection against viral infections by chemokine-accelerated post-exposure vaccination

  2024cites this paper
• Innate lymphoid cells and innate-like T cells in cancer — at the crossroads of innate and adaptive immunity

  2023cites this paper
• α-Galactosylceramide and its analog OCH differentially affect the pathogenesis of ISO-induced cardiac injury in mice

  2020cites this paper
• Intranasal Therapeutic Peptide Vaccine Promotes Efficient Induction and Trafficking of Cytotoxic T Cell Response for the Clearance of HPV Vaginal Tumors

  2020cites this paper
• Codelivery of mRNA with α-Galactosylceramide Using a New Lipopolyplex Formulation Induces a Strong Antitumor Response upon Intravenous Administration

  2019cites this paper
• Sphingolipids in early viral replication and innate immune activation

  2018cites this paper
• Optimisation de l'activité immunostimulatrice des lymphocytes T Natural Killer invariants : conséquences sur l'immunité anti-tumorale

  2017cites this paper
• Small-Molecule Carbohydrate-Based Immunostimulants.

  2017cites this paper
• Thermostability of the coating, antigen and immunostimulator in an adjuvanted oral capsule vaccine formulation.

  2017cites this paper
• Effects of ageing on murine NKT cell and macrophage populations

  2017cites this paper
• Engaging Natural Killer T Cells as ‘Universal Helpers’ for Vaccination

  2016cites this paper
• Co-operation of α-galactosylceramide-loaded tumour cells and TLR9 agonists induce potent anti-tumour responses in a murine colon cancer model.

  2016cites this paper
• Novel Types of Small RNA Exhibit Sequence- and Target-dependent Angiogenesis Suppression Without Activation of Toll-like Receptor 3 in an Age-related Macular Degeneration (AMD) Mouse Model

  2015cites this paper
• Inhibition of indoleamine 2,3‐dioxygenase activity enhances the anti‐tumour effects of a Toll‐like receptor 7 agonist in an established cancer model

  2015cites this paper
• Activated NKT Cells Can Condition Different Splenic Dendritic Cell Subsets To Respond More Effectively to TLR Engagement and Enhance Cross-Priming

  2015cites this paper
• Combination therapy with α-galactosylceramide and a Toll-like receptor agonist exerts an augmented suppressive effect on lung tumor metastasis in a mouse model.

  2015cites this paper
• Dendritic cell SIRT1–HIF1α axis programs the differentiation of CD4+ T cells through IL-12 and TGF-β1

  2015cites this paper
• "Pruning of biomolecules and natural products (PBNP)": an innovative paradigm in drug discovery.

  2015cites this paper
• α‐Galactosylceramide stimulates splenic lymphocyte proliferation in vitro and increases antibody production in vivo in late neonatal‐age mice

  2015cites this paper
• Enhance Cross-Priming More Effectively to TLR Engagement and Splenic Dendritic Cell Subsets To Respond Activated NKT Cells Can Condition Different

  2015cites this paper
• NK and NKT Cell Depletion Alters the Outcome of Experimental Pneumococcal Pneumonia: Relationship with Regulation of Interferon-γ Production

  2015cites this paper
• An autologous leukemia cell vaccine prevents murine acute leukemia relapse after cytarabine treatment.

  2014cites this paper